FranceOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 2,193 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52,040 | 54,213 |
| Total Cites | 62,538 | 69,822 |
| H-index | 82 | 85 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 18 | 21 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 1,659 | 1,832 |
| Number of Single+First+Last Authored Papers | 150 | 150 |
| Total Cites to Single+First+Last Authored Papers | 4,716 | 5,160 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 40,046 | 42,478 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.64 |
| Self-Citation Percentage |
10.43%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 2,288 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53,521 | 55,924 |
| Total Cites | 56,501 | 63,146 |
| H-index | 76 | 79 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 18 | 21 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 1,545 | 1,699 |
| Number of Single+First+Last Authored Papers | 147 | 147 |
| Total Cites to Single+First+Last Authored Papers | 4,392 | 4,814 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 36,259 | 38,478 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.64 |
| Self-Citation Percentage |
10.52%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 2,445 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57,203 | 59,554 |
| Total Cites | 43,741 | 49,023 |
| H-index | 65 | 68 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 18 | 21 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 1,267 | 1,396 |
| Number of Single+First+Last Authored Papers | 138 | 138 |
| Total Cites to Single+First+Last Authored Papers | 3,665 | 4,037 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 28,211 | 30,011 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.63 |
| Self-Citation Percentage |
10.77%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 2,568 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60,371 | 62,989 |
| Total Cites | 40,778 | 45,680 |
| H-index | 63 | 66 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 16 | 19 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1,141 | 1,254 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 3,400 | 3,749 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 26,259 | 27,927 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.64 |
| Self-Citation Percentage |
10.73%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.